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Abstract
In order to minimize pathogen transmission, all blood do-
nors should be appropriately screened for infectious agents. 
Screening for Bartonella spp. infection in feline blood donors 
is a recommended practice in veterinary blood banks across 
the world.
The aim of this study was to compare results of an indirect 
immunofluorescence antibody test (IFAT) in identifying Bar-
tonella henselae antibodies with the results of PCR amplifi-
cation of Bartonella spp. DNA to establish the best IFAT cut 
off to identify non-bacteremic cats. A secondary aim of this 
study was to evaluate demographic and clinicopathologic fac-
tors that may be associated with Bartonella henselae infection 
status. From a population of stray cats in Milan city, 82 serum 
samples were evaluated by IFAT for Bartonella henselae anti-
bodies and PCR was performed on 90 whole blood samples 
for amplification of Bartonella spp. DNA. A total of 14/82 
(17.1%) samples were seropositive with an IFAT titer ≥1:64 
(cut-off for infection). Bartonella spp. DNA was identified in 
11/90 (12.2%) samples by PCR.
Overall 20/90 (22.2%) infected cats were identified by either 
IFAT ≥1:64 and/or PCR-positive results. Hyperbetaglobu-
linemia (P=0.02) and originating from zone 2 of Milan city 
(P=0.03) were statistically associated with positive Bartonella 
infection status.
The overall IFAT sensitivity was 50.0%, specificity 87.5%, 
positive predictive value 35.7% and negative predictive value 
was 92.65%. The ROC analysis showed that the area under the 
curve was 0.747 (P=0.0032) and that an IFAT cut off<1:32 had 
the highest sensitivity in identifying Bartonella PCR-negative 
cats. When feline blood donors undergo serological screening 
for Bartonella henselae infection an IFAT cut off <1:32 has the 
highest sensitivity for identifying non-bacteremic cats. How-
ever some serologically negative cats could be bacteremic and 
therefore screening of a feline blood donor using a combina-
tion of IFAT and PCR is recommended. Protein electrophore-
sis should be performed in all potential donor cats.
Introduction
Feline transfusion medicine is a new and rapidly growing 
specialization in veterinary medicine and many cats are now 
included as blood donors in blood donation programs. The 
quality of feline blood collected for transfusion depends on 
many factors. In addition to immune-mediated reactions 
caused by infusion of allogeneic cells or proteins, adverse 
transfusion events can be caused by infectious agents from 
transfusion of contaminated blood obtained from an infected 
donor. Therefore, to minimize pathogen transmission, all 
blood donors should be appropriately screened for infectious 
agents. Testing is recommended for pathogens which meet 
at least three of the following criteria: (1) the pathogen has 
been documented to cause clinical infection in recipients af-
ter blood transmission, (2) the pathogen is capable of causing 
subclinical infection such that carriers might inadvertently be 
identified as healthy blood donors, (3) the pathogen can be 
detected using culture or molecular methods from the blood 
of an infected animal, and (4) the resultant infection in the 
recipient has the potential to cause life-threatening illness and 
be difficult to eliminate with antimicrobial drugs [1,2].
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Bartonella henselae infection in cats meets all these criteria. 
Bartonella can induce chronic and persistent infection fol-
lowing blood transfusion. Infection can be latent and induce 
unpredictable recurrence of bacteremia [3-5] and cause signs 
such as transient lethargy, fever, neurologic dysfunction, re-
productive failure, and mild anemia [3-6]. Infected cats, may 
be highly bacteremic for several months with no significant 
clinical signs [7]. Although Bartonella infection is usually 
asymptomatic, or characterized by mild clinical signs in other-
wise healthy cats, infection is a significant problem in immu-
nocompromized individuals (such as recipients of blood trans-
fusion), who get the most serious forms of bartonelloses. In 
addition, it has been shown in man that blood storage does not 
inactivate B. henselae which can remain viable in RBC units 
for up to 35 days at 4°C [8]. Finally no antibacterial therapy is 
available to clear the pathogen from cats [9,10]. For all these 
reasons screening for Bartonella spp infection in feline blood 
donors is a recommended practice in veterinary blood banks 
around the world [1,2].
Detection of B. henselae in blood is the gold standard in diag-
nosis of Bartonella infection in cats [9,10] and the best method 
to identify bacteremic cats. However there are some limita-
tions in the identification of Bartonella henselae in blood by 
blood culture: a prolonged incubation period (4 to 6 weeks) 
[3,11], requirement for a specialized laboratory, possibility of 
false negative results because cultivation on media is very dif-
ficult (particularly when a low number of bacteria are present 
in peripheral blood at time of collection) or because the organ-
ism died in transport to the laboratory. In addition cats can 
be intermittently bacteremic showing wide fluctuations in the 
levels of bacteremia over time with intermittent negative cul-
ture [5,6]. To reduce false-negative test results, repeated blood 
cultures are required. All these factors limit the utility of bacte-
rial culture as a diagnostic tool for routine screening of blood 
donors.
Molecular biology methods such as Polymerase Chain Reac-
tion (PCR) are more suitable for screening feline blood donors 
for Bartonella spp. infection. PCR is a specific and sensitive 
method and rapidly detects the presence of Bartonellae in fe-
line blood samples. However PCR assays require specialized 
laboratories, stringent quality control to avoid both false-pos-
itive and false-negative results, can be expensive to perform, 
and are currently not standardized among laboratories [9]. In 
addition, whilst true positive PCR assay results document the 
presence of microbial DNA, they do not prove the organism 
was alive and therefore capable of inducing infection in blood 
recipients. False-negative PCR assay results could occur be-
cause of intermittent bacteremia, previous use of antibiotics, 
lack of microbial DNA in the sample tested, or inhibitory or 
interfering substances in biologic specimens [9]. In addition, 
Economic factors in veterinary medicine often limit the testing 
of blood donor animals. Some tests such as PCR could be cost 
prohibitive for some blood donor programs.
The use of an Indirect Immunofluorescence Antibody Test 
(IFAT) as an alternate to PCR testing for Bartonella hense-
lae infection in feline blood donors has been included in the 
guidelines provided by European Advisory Board on Cat dis-
eases (ABCD) group for minimizing risks of iatrogenic infec-
tious complications in feline blood transfusion [2]. Serum an-
tibody tests can be performed more quickly than blood culture 
and are inexpensive when compared to PCR.
The aim of this study was to compare results of IFAT in iden-
tifying Bartonella henselae antibodies and the results of PCR 
in amplifying Bartonella spp. DNA in order to identify the 
best IFAT cut off for identification of non-bacteremic cats. In 
addition, as clinical diagnosis of bartonellosis is complicated 
by poor understanding of the clinical spectrum of Bartonella 
infection, the second aim of this study was to evaluate demo-
graphic and clinicopathologic factors that may be associated 
with Bartonella henselae infection status. 
Abbreviation
AUC:  Area Under Curve; BCS:  Body Condition Score; 
CBC:  Complete Blood Counts; CI: Confidence In-
terval; IFAT:  Indirect Immunofluorescent Antibody Test; 
NLR: Negative Likelihood Ratio; NPV: Negative Predic-
tive Value; PCR:  Polymerase Chain Reaction; PLR: Positive 
Likelihood Ratio; PPV:  Positive Predictive Value; ROC: 
Receiving Operator Characteristic; TNR: Trap, Neuter and 
Release
Materials and Methods
Animals and Blood Samples 
Frozen serum and whole blood samples from previously iden-
tified seropositive cats [12] were used for this study. These 
samples were collected from cats between June and December 
2014 during a survey on stray cats from Milan city in Northern 
Italy (Latitude: 45°27’51’’N, Longitude: 9°11’22’’E). The study 
population comprised 90 stray cats captured from courtyards 
in urban areas of Milan for a trap, neuter, and release (TNR) 
sterilization program performed as part of a national program 
to control stray pet populations under Italian National Law 
(law no. 281/1991). Interventions for the prevention, diagno-
sis, therapy, and control of diseases in stray feline populations 
are allowed under Lombardy regional law no. 33/2009; there-
fore, approval of the study design by an ethics committee was 
not necessary. In the previous study [12] serum samples were 
screened with an IFAT for Bartonella henselae IgG antibody 
with the highest screened antibody titer of 1:128. In the pre-
sent study the previous IFAT positive serum samples were ana-
lyzed for the end point IFAT titer for B. henselae. In addition 
whole blood samples of these 90 cats were analyzed by PCR to 
amplify Bartonella DNA. Data available for each cat were age 
(adult or young cats, based on dentition), gender, body condi-
tion score (BCS), colony of origin, clinical disorders diagnosed 
in the cats at the time of sample collection, complete blood 
counts (CBC), total serum protein and protein electrophoresis 
(albumin, alpha-, beta-, and gamma-globulin concentrations).
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Serological analysis
Bartonella henselae IgG antibodies were detected using a com-
mercially available IFAT kit (Biopronix Product Line, Agrolabo 
Spa, Italy) using slides prepared with fixed B. henselae-infected 
Hep-2 cells. All sera were diluted 1:32 in phosphate-buffered 
saline (PBS, pH 7.2) and incubated on wells of the slides at 
37°C in a humidity chamber for 30 min. The slides were rinsed 
twice in PBS, once in distilled water and air-dried. Each well 
of the slides was probed with fluorescein isothiocyanate-con-
jugated sheep anti-Cat IgG (Biopronix-Agrolabo Spa, Italy) 
diluted 1:50 in Evans Blue solution and incubated at 37°C in 
a humidity chamber for 30 min. The slides were washed and 
dried as described above and examined with a fluorescence 
microscope. Sera were screened starting from 1:32 dilution, 
and any serum sample positive at that dilution was titrated in 
serial twofold dilutions to the endpoint titer. Cut-off value for 
B. henseale infection was ≥1:64 [11,13,14]. Negative and posi-
tive control samples were included on each slide. Slides were 
examined by fluorescence microscopy at 40× magnification 
(Axioskop, Zeiss, Germany), as previously described [6].
DNA extraction and PCR
DNA was extracted from feline blood samples using the High 
Pure Template Preparation Kit (EZNA tissue DNA kit, VWR-
Omega Bio-Tek, USA), following the manufacturer’s instruc-
tions. The DNA samples were stored at -20°C until used as 
template in PCR protocols. The primers p24E and p12B, previ-
ously described [15], were used in this protocol to amplify a 
296 bp fragment of the Bartonella 16S rRNA gene. The PCR 
amplification was performed in 25 µl of reaction mixtures con-
taining 0.5 µl of deoxynucleoside triphosphates (GeneAmp 
dNTP Mix with dTTP, Applied Biosystems, Life Technologies, 
UK), 0.5 µl of each primer, 0.125 µl of Taq polymerase and 5 
µl of PCR buffer (GoTaq G2 Polymerase, Promega), 16.375 µl 
of Nuclease free water and 2 µl of extracted DNA. PCR am-
plifications were performed in an automated thermal cycler 
(Thermal Cycler 2720, Applied Biosystems, UK) for 55 cycles. 
Each cycle consisted of denaturation at 94 °C for 15 seconds, 
annealing at 66°C for 15 s, extension at 72 °C for 15 s; an initial 
denaturation of 2 min at 95 °C and a final extension of 1 min 
at 72°C. PCR controls included a known positive DNA extract 
and a reagent blank. PCR products were analyzed by electro-
phoresis on 1.5% agarose (EURx) gel at 100 V for 45 min; the 
gel was stained with ethidium bromide and examined. The 
DNA molecular weight marker was 100 bp DNA Ladder (Pro-
mega, USA).
Statistical analysis
Cats were divided into 2 groups, Bartonella henselae infected 
and non-infected with an IFAT titer ≥1:64 and/or PCR-pos-
itive result and an IFAT titer <1:64 and/or PCR-negative re-
sult, respectively. Titers below 1:32 were considered as zero 
in the analysis. For univariate analyses, nonparametric tests 
(Chi-square or Fisher’s exact test) were used to test for associa-
tions between infective and non-infective status and putative 
explanatory factors or risk factor for infection status, such as 
age, gender, BCS, colony of origin, clinical, hematological and 
electrophoretic alterations.
Associations between serological results and PCR status were 
tested with a Fisher exact test. For comparison of IFAT titers 
in PCR-positive and negative cats, non-parametric Mann–
Whitney rank sum test was used. Calculation of sensitivity 
(Se), specificity (Sp), positive likelihood ratio (PLR), negative 
likelihood ratio (NLR), positive predictive value (PPV), nega-
tive predictive value (NPV), was performed for evaluation of 
IFAT results in comparison of PCR status as reference stand-
ard. To assess performance of the IFAT test at different cut offs, 
Se, Sp, NLR, PLR, NPV and PPV were calculated generating 
a receiving operator characteristic (ROC) curve using PCR as 
criterion-reference standard and a prevalence of Bartonella 
henselae infection in stray cats of Milan city of 16% [13]. The 
performance of the IFAT test was analyzed by comparing the 
area under the curve (AUC), with 1 indicating a perfect test 
and 0.5 indicating results similar to chance. The area under the 
ROC curve provides a single numerical estimate of overall ac-
curacy that can be interpreted as the average probability that 
an infected animal will have a positive test value compared to 
a non-infected animal. All statistical analysis were performed 
using MedCalc Statistical Software version 16.8.4 (MedCalc 
Software bvba, Ostend, Belgium; https://www.medcalc.org; 
2016).
Results 
Serology 
The IFAT detected 23/82 (28.1%) serum samples with six dif-
ferent end point antibody-titers against B. henselae (Table 1). 
There were 14/82 (17.1%) seropositive samples with an IFAT 
titer ≥1:64 (cut-off for infection).
Polymerase chain reaction
Amplification of Bartonella spp. DNA by PCR was possible in 
11/90 (12.2%) samples. 
Overall 20/90 (22.2%) cats were infected (i.e. IFAT ≥1:64 and/
or PCR-positive results).
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Endpoint IFAT antibody titer No. of cats (%) No. of Bartonella henselae 
PCR-positive cats (%)
P-value (Fisher’s exact test)
<1:32 59 (71.9) 3 (30.0) 0.004
1:32 9 (11.0) 2 (20.0) 0.301
1:64 3 (3.7) 1 (10.0) 0.326
1:128 3 (3.7) 2 (20.0) 0.037
1:256 5 (6.1) 2 (20.0) 0.110
1:512 2 (2.4) 0 (0.0) 1.000
1:1024 1 (1.2) 0 (0.0) 1.000
Total 82 (100) 10 (100) -
Table 1. Bartonella henselae IFAT end point titers and comparison with PCR results for Bartonella spp. in 82 stray cat of Milan city, 
northern Italy.
P value in bold are statistically signicant as ≤ 0.05
Risk factor study 
Summary statistics relating to CBC and protein electrophoresis profile are reported in Table 2.
Parameter Min Max Mean (95% CI) ±DS
RBC (x10-6/μL) 5.50 10.50 7.98 (7.38-8.57) 1.27
Hb (g/dl) 6.8 12.7 10.1 (9.5-10.8) 1.4
Hct (%) 20.1 39.6 29.7 (27.4-32) 4.9
MCV (f) 28.2 47.2 37.3 (35.5-39.2) 3.9
MCH (pg) 9.1 18 12.8 (12-13.7) 1.8
MCHC (g/dl) 31.9 49.2 34.4 (32.7-36.2) 3.8
RDW (%) 15.2 27.6 19.6 (18.2-20.9) 2.9
PLT (x10-3/ml) 43 567 326 (247-405) 168
WBC (x10-3/ml) 5.9 20.3 11.6 (9.7-13.5) 3.9
Neutrophil (%) 19 83 59.8 (52.5-67.1) 15.6
Lymphocytes (%) 10 73 31 (24.2-37.7) 14.3
Monocytes (%) 0 7 2.9 (2.1-3.7) 1.7
Basophils (%) 0 3 0.7 (0.3-1.1) 0.8
Eosinophils (%) 1 15 5.4 (3.5-7.3) 3.9
Total protein (g/dl) 5.6 7.6 6.4 (6.1-6.7) 0.6
Albumin (%) 36.2 52.9 46.1 (43.8-48.3) 4.6
Alpha 1 globulin (%) 1.7 4.4 3.3 (3-3.7) 0.6
Alpha 2 globulin (%) 15 23.8 19.5 (18.1-20.9) 2.8
Beta 1 globulin (%) 2.1 7.6 5.7 (5-6.3) 1.3
Beta 2 globulin (%) 2.5 6.3 4.1 (3.5-4.7) 1.2
Gamma globulin (%) 13.9 39.3 21.1 (17.9-24.3) 6.6
Albumin/globulin ratio 0.5 1.1 0.8 (0.7-0.9) 0.1
Table 2: Summary statistics relating to CBC, total protein and protein electrophoretic profile in 20 stray cats infected with Bar-
tonella henselae (infection status defined by IFAT≥1:64 and/or PCR positive result)
RBC: red blood cells; Hb: hemoglobin; Hct: hematocrit; PCV: packed cell volume; MCH: mean corpuscular hemoglobin; MCHC: 
mean corpuscular hemoglobin concentration; RDW: red cell distribution width; PLT: platelets; WBC: white blood cells.
The only categorical variables studied that showed a statistically significant association with Bartonella infection status (Table 3), 
were hyperbetaglobulinemia (P=0.02) and originating from zone 2 of Milan city (P=0.03).
  Clerisy Publishers         
 
                            J Vet Clin Pract Pet Care  2016 | Vol 1: 104
5
Characteristic Categories Total population Infected(n=20) Non-
infected(n=70)
P value 
Age Young (<6 months) 19 (21.1%) 1 (5.3%) 18 (94.7%) 0.84
Adult (>6 months) 71 (78.9%) 19 (26.8%) 52 (73.2%)
Gender Female 54 (60%) 13 (24.1%) 41 (75.9%) 0.79
Male 36 (40%) 7 (19.4%) 29 (80.6%)
BCS Poor (<3/9) 13 (14.5%) 2 (15.4%) 11 (84.6%) 0.65
Good (>4/9) 77 (85.5%) 18 (23.4%) 59 (76.6%)
Colony of 
Origin Zone 1 11 (12.2%) 2 (18.2%) 9 (81.8%) 1.00
Zone 2 20 (22.2%) 1 (5.0%) 19 (95.0%) 0.03
Zone 3 4 (4.4%) 1 (25.0%) 3 (75.0%) 1.00
Zone 4 3 (3.3%) 0 (0.0%) 3 (100.0%) 1.00
Zone 5 12 (13.3%) 2 (16.7%) 10 (83.3%) 1.00
Zone 6 1 (1.1%) 0 (0.0%) 1 (100.0%) 1.00
Zone 7 11(12.2%) 4 (36.4%) 7 (63.6%) 0.25
Zone 8 5 (5.5%) 1 (20.0%) 4 (80.0%) 1
Zone 9 17(18.8%) 6 (35.3%) 11 (64.7%) 0.26
Suburban 6 (6.7) 3 (50.0%) 3 (50.0%) 0.12
Clinical examina-
tion
Healthy 21 (23.3%) 4 (19.0%) 17 (81.0%) 1.00
Ill 69 (76.7%)  16 (23.2%) 53 (76.8%) 
Stomatitis 35 (38.9%) 8 (22.9%) 27 (77.1%) 0.98
Ocular discharge 4 (4.4%) 1 (25.0%) 3 (75.0%) 1
Nasal discharge 3 (3.3%) 1 (33.3%) 2 (66.7%) 0.53
Pale mucous membranes 5 (5.6%) 0 (0.0%) 5 (100.0%) 0.58
Lymphadenopathy 65 (72.2%) 15 (23.1%) 50 (76.9%) 1
CBC results
Presence of anemia (Hct <31.7%) 66 (75.0%) 14 (21.2%) 52 (78.8) 0.92
Decreased Hb (<10.6 g/dl) 60 (68.2%) 13 (21.7%) 47 (78.3%) 0.93
Decreased RBC (<6.56 x10-6/μl) 19 (21.6%) 1 (5.3%) 18 (94.7%) 0.06
Thrombocytopenia (<175 x10-3/
ml)
26 (29.5%) 4 (15.4%) 22 ( 84.6%) 0.78
Leukocytosis (>18.7 x10-3/ml) 6 (6.8%) 1 (16.7%) 5 (83.3%) 1
Leukopenia (<4.0 x10-3/ml) 1 (1.1%) 0 (0.0%) 1 (100%) 1
Neutrophilia (>14 x10-3/ml) 5 (5.7%) 1 (20.0%) 4 (80%) 1
Neutropenia (<2.3 x10-3/ml) 2 (2.3%) 1 (50.0%) 1 (50%) 0.39
Lymphocytosis (>6.1 x10-3/ml) 6 (6.8%) 1 (16.7%) 5 (83.3%) 1
Lymphopenia (<0.8 x10-3/ml) 2 (2.3%) 0 (0.0%) 2 (100.0%) 1
Eosinophilia (>1.5 x10-3/ml) 6 (6.8%) 1 (16.7%) 5 (83.3%) 1
Proteinemia and 
Electrophoresis
Hyperproteinemia (6-8 g/dl) 3 (3.9%) 0 (0.0%) 3 (100.0%) 1
Hyperalbuminemia (42-56.6%) 2 (2.63%) 0 (0.0%) 2 (100.0%) 1
Hyperαglobulinemia (1-3%) 49(64.4%) 13 (26.5%) 36 (73.5%) 0.76
Hyperβglobulinemia (5.8-8%) 10 (13.1%) 5 (50.0%) 5 (50.0%) 0.02
Hyperγglobulinemia (13-25.2%) 16 (21.1%) 4 (25.0%) 12 (75.0%) 1.00
Table 3: Categorization of different variables in Bartonella henselae infected and non-infected cats and study for the association 
in a population of 90 stray cats of northern Italy. (P value in bold are statistically significant as ≤ 0.05)
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BCS: body condition score; CBC: complete blood cell count; 
RBC: red blood cells; Hb: hemoglobin; Hct: hematocrit; PCV: 
packed cell volume; MCH: mean corpuscular hemoglobin; 
MCHC: mean corpuscular hemoglobin concentration; RDW: 
red cell distribution width; PLT: platelets; WBC: white blood 
cells.
Comparison between IFAT and PCR 
results
A total of 82 samples were analyzed by both IFAT and PCR, 
of these 14 (17.1%) were seropositive (IFAT titer ≥1:64) and 
10 (12.2%) PCR-positive for amplification of Bartonella DNA. 
Five cats out of 82 (6.1%) were both PCR-positive and sero-
positive for B. henselae. Comparison between IFAT and PCR 
results is reported in Table 4.
Status of cat PCR results Total
Positive Negative 
IFAT sero-
positive 
5 9 14
IFAT seron-
egative 
5 63 68
Total 10 72 82
Table 4: Comparison between bacteremia and seropositivity 
for Bartonella  ssp. infection results in 82 cats in northern Italy.
All PCR-positive cats had antibody titers ≤1:256 and none had 
the highest antibody titer of 1:1024. Antibody titers were not 
significantly higher (Mann-Whitney test, P=0.06) in PCR-
positive cats (highest IFAT titer, 1:256) than in PCR-negative 
cats (highest IFAT titer, 1:1024). A statistically significant as-
sociation was found between IFAT titers <1:32 (P=0.004) and 
1:128 (P=0.037) and PCR results (Table 1). Overall IFAT Se 
was 50.0% (95%CI 18.7-81.2), Sp 87.5% (95%CI 77.5-94.1), 
PLR 4.0 (95%CI 1.6-9.5), NLR 0.5 (95%CI 0.3-1.0), PPV 35.7% 
(95%CI 12.7-64.8) and NPV 92.6% (95%CI 83.6-97.5). The 
ROC analysis showed that the area under the curve was 0.747 
(95% CI, 0.638 to 0.836, Standard error =0.0836, Z statistic 
=2.950) and was significantly higher (P=0.0032) than 0.5 (the 
value of area indicating no diagnostic utility) (Figure- 1). With 
the PCR assay considered the gold standard in identifying bac-
teremic cats (PCR-positive samples), the diagnostic sensitivity 
and specificity, PPV and NPV of the IFAT at different anti-
body titers is reported in Table 5. The ROC analysis identified 
that sensitivity of 100% was achieved at IFAT antibody titer of 
<1:32.
Discussion 
Results of epidemiologic studies have indicated that the world-
wide prevalence of Bartonella spp. bacteremia in cats ranges 
from 15% to 55%. In our study 11/90 cats (12.2%) were con-
sidered bacteremic, since they tested positive with the PCR as-
say specific for the Bartonella genus. This prevalence is lower 
than that suggested by worldwide data but higher than pre-
vious data on bacteremia in stray cats of Milan city in which 
prevalence was 5.4% [13]. IFAT was positive for B. henselae 
antibodies in 14/82 (17.1%) cats, but only 5 of these seroposi-
tive cats (35.7%) were considered bacteremic, since they were 
positive with the PCR assay specific for the Bartonella genus. 
Half of bacteremic cats were seronegative and all cats showed 
low anti-Bartonella antibody levels (all PCR-positive cats had 
IFAT antibody titers ≤1:256). In addition the highest PCR-
positive prevalence (30.0%) was significantly associated with 
IFAT titers <1:32.
These results suggest that, as previously demonstrated [16], 
serological testing, and in particular IFAT, appear to be of lim-
ited value for predicting bacteremia. In fact the IFAT had a low 
PPV (35.7%), and thus is of limited utility in distinguishing 
between bacteremic and non-bacteremic cats. However, the 
inability to detect B. henselae antibodies appears to be highly 
predictive of the absence of bacteremia (NPV = 92.7%), and 
therefore, serologically negative cats may be more suitable for 
inclusion in a feline blood donor program, bearing in mind 
that bacteremic cats could be serologically negative. These re-
sults are in agreement with previous studies, which also found 
that serology (IFAT or ELISA) is more useful for exclusion 
than for confirmation of the infection because of the low PPV 
(39–46%) compared with the good NPV (87–97%) [13,16-18]. 
Therefore cats with positive Bartonella spp. test results should 
not be selected as blood donors. Cats with negative Bartonella 
spp. test results are less likely to be harboring the organism and 
so may be safer donors than cats with positive Bartonella spp. 
test results [9].
ROC analysis found that ideal IFAT cut-off with higher NPV 
and sensitivity was at titer <1:32, in practice this is cats with 
no anti Ig-Bartonella henselae antibodies. No association was 
found between infection and clinical or hematological altera-
tions and this is in accordance with previous studies in natural 
and experimentally infected cats [4,5,19,20], and in accordance 
with the fact that the natural infection is usually asymptomatic 
in cats, or characterized by mild clinical signs. These data sup-
port the hypothesis that cats, even if clinically healthy, can rep-
resent a reservoir for Bartonella-associated infection. Only one 
study found associations between antibodies to Bartonella spp. 
and lymphocytosis [14]. Hyperglobulinemia, primarily due 
to polyclonal gammopathy, was significantly associated with 
seropositivity to Bartonella species in one study [21] and this 
was partially in accordance with the significant hyperbetaglob-
ulinemia that we found in our study in Bartonella spp. infected 
cats (P=0.02).
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Figure 1. ROC curve for IFAT detection of anti-Bartonella henselae IgG antibodies. The Y-axis shows the false positive rate 
(specificity), and the X-axis shows the true positive rate (sensitivity). A test with the perfect discrimination has a ROC curve 
that passes through the upper leſt corner. The area under the curve (AUC) is = 0.747 (P= 0.0032). The ROC analysis shows 
that the cutoff point for the test with the best sensitivity is = 0 (Se: 100.0%; Sp: 0.0%). 
Criterion Sensi-
tivity
95% CI Speci-
ficity
95% CI PLR 95% CI PLR 95% CI PPV 95% CI PP
V
95% 
CI
≥0 100.00 69.2 - 
100.0
0.00 0.0 - 
5.0
1.00 1.0 - 
1.0
  16.0 8.8 - 
25.8
  
>0 70.00 34.8 - 
93.3
77.78 66.4 - 
86.7
3.15 1.7 - 
5.7
0.39 0.1 - 
1.0
37.5 19.0 - 
59.2
93.2 83.3 - 
98.1
>1:32 50.00 18.7 - 
81.3
87.50 77.6 - 
94.1
4.00 1.7 - 
9.6
0.57 0.3 - 
1.1
43.2 18.8 - 
70.4
90.2 80.4 - 
96.1
>1:64 40.00 12.2 - 
73.8
91.67 82.7 - 
96.9
4.80 1.6 - 
14.1
0.65 0.4 - 
1.1
47.8 18.3 - 
78.4
88.9 79.2 - 
95.1
>1:128 20.00 2.5 - 
55.6
93.06 84.5 - 
97.7
2.88 0.6 - 
12.9
0.86 0.6 - 
1.2
35.4 6.8 - 
75.3
85.9 75.9 - 
92.9
>1:256 0.00 0.0 - 
30.8
97.22 90.3 - 
99.7
0.00  1.03 1.0 - 
1.1
0.0 0.0 - 
85.5
83.6 73.7 - 
90.9
>1:512 0.00 0.0 - 
30.8
98.61 92.5 - 
100.0
0.00  1.01 1.0 - 
1.0
0.0 0.0 - 
97.9
83.8 74.0 - 
91.1
>1:1024 0.00 0.0 - 
30.8
100.00 95.0 - 
100.0
  1.00 1.0 - 
1.0
  84.0 74.2 - 
91.2
Table 5. Sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), positive predictive value 
(PPV), negative predictive value (NPV) of IFAT test compared to PCR results in identifying bacteremic cats for Bartonella 
spp.
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Increased globulin concentrations can be explained by the 
prolonged bacteremia that can be associated with infection by 
Bartonella spp. However in Bartonella infections both co-in-
fections and serial reinfection have been documented in cats, 
both of which could contribute to development of polyclonal 
gammopathy in a cross sectional study such as this. Causality 
cannot be determined by analysis of cross-sectional data and it 
was not possible to test these cats a second time in this study. 
There were a number of limitations to this study. The primary 
limitation is the small sample size, which limits the statistical 
significance of results.
The secondary limitation is the population studied. Free-
roaming stray cats should never be considered as potential 
donors, as they are high-risk cats for blood-borne pathogens, 
as demonstrated by previous studies in stray cats in northern 
Italy [12,21-23]. Stray cats have a higher prevalence of Bar-
tonella spp. infection than pet cats, mainly due to close con-
tact between infected animals in large groups of cats [24]. 
Although stray cats represent a sentinel population for a vari-
ety of infections, because they receive no prophylaxis and are 
continually exposed to disease vectors, they provide limited 
data due to the absence of important anamnestic and clinical 
information. However stray cats undergoing sterilization in 
TNR program are usually young cats, and the prevalence of 
Bartonella henselae bacteremia in young cats (< 1 year old) is 
usually higher than it is in adult cats [16,17]. Other than young 
age, recognized risk factors for Bartonella bacteremia in cats 
are infestation with fleas, outdoor lifestyle and a multicat envi-
ronment [9,14,16,17]. Stray cats population are therefore high 
risk population for Bartonella spp. bacteremia and this could 
facilitate the finding of infected cats whose blood samples are 
useful in evaluation and comparison of diagnostic methods. In 
addition with flea infestations of peridomestic animals, stray 
colony cats contribute to the maintenance of these organisms 
in close proximity to household environments, and therefore 
give important information on the risk of Bartonella spp. in-
fection for pet cats that share their environments.
Another limitation is that Bartonella was investigated only at 
the genus level, as amplicons derived from blood were not se-
quenced to distinguish between B. henselae and B. clarridgeiae 
PCR products and therefore information about the species in-
fecting the study population was lacking. Cats have been rec-
ognized as a reservoir of Bartonella clarridgeiae [7]. However, 
it is likely that B. clarridgeiae is present at very low frequencies 
in the cat population in Italy [11,13,19].
 
Finally, other organisms such as Chlamydia spp. and Coxiella 
burnetii, have been associated with serological cross-reactions 
in people [26,27] and the same could happen in cats. It is 
known that antibodies against B. henselae generally cross react 
with B. clarridgeiae and other Bartonella spp. How these cross-
reactions falsely influence the results of serological analysis de-
rived from cats is not known.
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Conclusion
The highest sensitivity for identification of Bartonella spp. non-
bacteremic cats for inclusion in a feline blood donor program 
is achieved by using an IFAT cut-off <1:32. However serologi-
cally negative cats may still be bacteremic for Bartonella spp. 
Therefore feline blood donors should be screened using both 
IFAT and PCR (as suggested as the minimum standard by the 
Consensus Statements of the American College of Veterinary 
Internal Medicine for the screening of feline blood donors for 
blood-borne pathogens [1]. Protein electrophoresis should be 
performed in all cats to be evaluated as blood donors.
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